Pancreatic Cancer
A Randomized, Double-Blind, Phase 3 Study of Chemotherapy With orWithout INCB161734 in Previously Untreated, KRAS G12D–MutatedMetastatic Pancreatic Ductal Adenocarcinoma (DAWN-303)
- Details
ClinicalTrials.gov ID:
NCT07522073
Diagnosis Type:
NA
USOR Number:
- Address
,
P: